Applicability of Diagnostic Criteria and High Prevalence of Familial Dysbetalipoproteinemia in Russia: A Pilot Study.

APOE apolipoprotein B apolipoprotein E autosomal dominant familial dysbetalipoproteinemia genetic hyperlipidemia hyperlipoproteinemia type III population remnant lipoproteins

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Aug 2023
Historique:
received: 31 05 2023
revised: 14 08 2023
accepted: 22 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Familial dysbetalipoproteinemia (FD) is a highly atherogenic genetically based lipid disorder with an underestimated actual prevalence. In recent years, several biochemical algorithms have been developed to diagnose FD using available laboratory tests. The practical applicability of FD diagnostic criteria and the prevalence of FD in Russia have not been previously assessed. We demonstrated that the diagnostic algorithms of FD, including the diagnostic apoB levels, require correction, taking into account the distribution of apoB levels in the population. At the same time, a triglycerides cutoff ≥ 1.5 mmol/L may be a useful tool in identifying subjects with FD. In this study, a high prevalence of FD was detected: 0.67% (one in 150) based on the ε2ε2 haplotype and triglycerides levels ≥ 1.5 mmol/L. We also analyzed the presence and pathogenicity of

Identifiants

pubmed: 37685967
pii: ijms241713159
doi: 10.3390/ijms241713159
pmc: PMC10487848
pii:
doi:

Substances chimiques

Apolipoproteins B 0
Triglycerides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Arch Med Sci. 2019 Aug 02;16(5):993-1003
pubmed: 32863987
J Clin Lipidol. 2021 Jan-Feb;15(1):104-115.e9
pubmed: 33189625
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Clin Chem. 1997 Dec;43(12):2364-78
pubmed: 9439456
Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):133-139
pubmed: 28098593
Clin Biochem. 2018 Sep;59:31-36
pubmed: 29928902
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Atherosclerosis. 2021 Jul;328:11-22
pubmed: 34058468
Hum Genet. 2020 Oct;139(10):1197-1207
pubmed: 32596782
Clin Genet. 2022 Oct;102(4):253-261
pubmed: 35781703
Nat Rev Endocrinol. 2010 Jun;6(6):335-46
pubmed: 20421882
Emerg (Tehran). 2015 Spring;3(2):48-9
pubmed: 26495380
Atherosclerosis. 2019 Mar;282:169-175
pubmed: 30463677
Reprod Sci. 2009 May;16(5):431-7
pubmed: 19233944
Am J Hum Genet. 1993 May;52(5):937-46
pubmed: 8488843
Semin Vasc Med. 2004 Aug;4(3):249-57
pubmed: 15630634
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):294-9
pubmed: 11834531
Atherosclerosis. 2015 May;240(1):90-7
pubmed: 25768710
Atherosclerosis. 2009 Dec;207(2):559-66
pubmed: 19524242
Nucleic Acids Res. 2015 Jan;43(Database issue):D789-98
pubmed: 25428349
Crit Rev Clin Lab Sci. 2014 Feb;51(1):46-62
pubmed: 24405372
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
J Lipid Res. 2009 Apr;50 Suppl:S183-8
pubmed: 19106071
Eur J Clin Invest. 1996 Jan;26(1):13-23
pubmed: 8682150
J Am Heart Assoc. 2021 Jul 20;10(14):e020215
pubmed: 34219465
Eur J Hum Genet. 2021 Dec;29(12):1796-1803
pubmed: 34521998
Prog Cardiovasc Dis. 2016 Sep - Oct;59(2):119-124
pubmed: 27481046
Curr Cardiol Rep. 2021 Sep 4;23(10):151
pubmed: 34480646
J Pers Med. 2021 May 24;11(6):
pubmed: 34074024
Pancreas. 2009 Aug;38(6):716-7
pubmed: 19629007
Eur Heart J. 2020 Jan 1;41(1):111-188
pubmed: 31504418
Lancet Diabetes Endocrinol. 2020 Jan;8(1):50-67
pubmed: 31582260
Front Genet. 2021 Oct 07;12:709419
pubmed: 34691145
Crit Rev Clin Lab Sci. 2020 Nov;57(7):458-469
pubmed: 32255405
J Clin Lipidol. 2020 Jul - Aug;14(4):431-437
pubmed: 32631794
J Clin Lipidol. 2017 Jan - Feb;11(1):12-23.e1
pubmed: 28391878
Clin Chem. 2019 Feb;65(2):313-320
pubmed: 30538126
Curr Atheroscler Rep. 2014 Sep;16(9):440
pubmed: 25079293
Front Genet. 2022 Feb 03;13:840797
pubmed: 35186049
Atherosclerosis. 2021 May;325:57-62
pubmed: 33892328

Auteurs

Anastasia V Blokhina (AV)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.

Alexandra I Ershova (AI)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.

Anna V Kiseleva (AV)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.

Evgeniia A Sotnikova (EA)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.

Anastasia A Zharikova (AA)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.

Marija Zaicenoka (M)

Phystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology, Institutskiy per. 9, 141701 Dolgoprudny, Russia.

Yuri V Vyatkin (YV)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
Department of Natural Sciences, Novosibirsk State University, 1, Pirogova Str., 630090 Novosibirsk, Russia.

Vasily E Ramensky (VE)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.

Vladimir A Kutsenko (VA)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
Faculty of Mechanics and Mathematics, Lomonosov Moscow State University, 1-73, Leninskie Gory, 119991 Moscow, Russia.

Svetlana A Shalnova (SA)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.

Alexey N Meshkov (AN)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.
National Medical Research Center for Cardiology, 3-ya Cherepkovskaya Street, 15A, 121552 Moscow, Russia.
Research Centre for Medical Genetics, 1 Moskvorechye St, 115522 Moscow, Russia.
Department of General and Medical Genetics, Pirogov Russian National Research Medical University, 1 Ostrovityanova st., 117997 Moscow, Russia.

Oxana M Drapkina (OM)

National Medical Research Center for Therapy and Preventive Medicine, Ministry of Healthcare of the Russian Federation, Petroverigsky per. 10, Bld. 3, 101000 Moscow, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH